Ginkgolic Acid Inhibits Protein SUMOylation by Blocking Formation of the E1-SUMO Intermediate

Isao Fukuda, Akihiro Ito, Go Hirai, Shinichi Nishimura, Hisashi Kawasaki, Hisato Saitoh, Ken ichi Kimura, Mikiko Sodeoka, Minoru Yoshida

Research output: Contribution to journalArticle

172 Citations (Scopus)

Abstract

Protein modification by small ubiquitin-related modifier proteins (SUMOs) controls diverse cellular functions. Dysregulation of SUMOylation or deSUMOylation processes has been implicated in the development of cancer and neurodegenerative diseases. However, no small-molecule inhibiting protein SUMOylation has been reported so far. Here, we report inhibition of SUMOylation by ginkgolic acid and its analog, anacardic acid. Ginkgolic acid and anacardic acid inhibit protein SUMOylation both in vitro and in vivo without affecting in vivo ubiquitination. Binding assays with a fluorescently labeled probe showed that ginkgolic acid directly binds E1 and inhibits the formation of the E1-SUMO intermediate. These studies will provide not only a useful tool for investigating the roles of SUMO conjugations in a variety of pathways in cells, but also a basis for the development of drugs targeted against diseases involving aberrant SUMOylation.

Original languageEnglish
Pages (from-to)133-140
Number of pages8
JournalChemistry and Biology
Volume16
Issue number2
DOIs
Publication statusPublished - Feb 27 2009
Externally publishedYes

Fingerprint

Small Ubiquitin-Related Modifier Proteins
Sumoylation
Neurodegenerative diseases
Proteins
Assays
Ubiquitination
Molecules
Neurodegenerative Diseases
Pharmaceutical Preparations
ginkgolic acid
anacardic acid

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmacology
  • Drug Discovery
  • Clinical Biochemistry

Cite this

Ginkgolic Acid Inhibits Protein SUMOylation by Blocking Formation of the E1-SUMO Intermediate. / Fukuda, Isao; Ito, Akihiro; Hirai, Go; Nishimura, Shinichi; Kawasaki, Hisashi; Saitoh, Hisato; Kimura, Ken ichi; Sodeoka, Mikiko; Yoshida, Minoru.

In: Chemistry and Biology, Vol. 16, No. 2, 27.02.2009, p. 133-140.

Research output: Contribution to journalArticle

Fukuda, I, Ito, A, Hirai, G, Nishimura, S, Kawasaki, H, Saitoh, H, Kimura, KI, Sodeoka, M & Yoshida, M 2009, 'Ginkgolic Acid Inhibits Protein SUMOylation by Blocking Formation of the E1-SUMO Intermediate', Chemistry and Biology, vol. 16, no. 2, pp. 133-140. https://doi.org/10.1016/j.chembiol.2009.01.009
Fukuda, Isao ; Ito, Akihiro ; Hirai, Go ; Nishimura, Shinichi ; Kawasaki, Hisashi ; Saitoh, Hisato ; Kimura, Ken ichi ; Sodeoka, Mikiko ; Yoshida, Minoru. / Ginkgolic Acid Inhibits Protein SUMOylation by Blocking Formation of the E1-SUMO Intermediate. In: Chemistry and Biology. 2009 ; Vol. 16, No. 2. pp. 133-140.
@article{dc45df43360c43bcae53cb6fffd71e4f,
title = "Ginkgolic Acid Inhibits Protein SUMOylation by Blocking Formation of the E1-SUMO Intermediate",
abstract = "Protein modification by small ubiquitin-related modifier proteins (SUMOs) controls diverse cellular functions. Dysregulation of SUMOylation or deSUMOylation processes has been implicated in the development of cancer and neurodegenerative diseases. However, no small-molecule inhibiting protein SUMOylation has been reported so far. Here, we report inhibition of SUMOylation by ginkgolic acid and its analog, anacardic acid. Ginkgolic acid and anacardic acid inhibit protein SUMOylation both in vitro and in vivo without affecting in vivo ubiquitination. Binding assays with a fluorescently labeled probe showed that ginkgolic acid directly binds E1 and inhibits the formation of the E1-SUMO intermediate. These studies will provide not only a useful tool for investigating the roles of SUMO conjugations in a variety of pathways in cells, but also a basis for the development of drugs targeted against diseases involving aberrant SUMOylation.",
author = "Isao Fukuda and Akihiro Ito and Go Hirai and Shinichi Nishimura and Hisashi Kawasaki and Hisato Saitoh and Kimura, {Ken ichi} and Mikiko Sodeoka and Minoru Yoshida",
year = "2009",
month = "2",
day = "27",
doi = "10.1016/j.chembiol.2009.01.009",
language = "English",
volume = "16",
pages = "133--140",
journal = "Cell Chemical Biology",
issn = "2451-9448",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Ginkgolic Acid Inhibits Protein SUMOylation by Blocking Formation of the E1-SUMO Intermediate

AU - Fukuda, Isao

AU - Ito, Akihiro

AU - Hirai, Go

AU - Nishimura, Shinichi

AU - Kawasaki, Hisashi

AU - Saitoh, Hisato

AU - Kimura, Ken ichi

AU - Sodeoka, Mikiko

AU - Yoshida, Minoru

PY - 2009/2/27

Y1 - 2009/2/27

N2 - Protein modification by small ubiquitin-related modifier proteins (SUMOs) controls diverse cellular functions. Dysregulation of SUMOylation or deSUMOylation processes has been implicated in the development of cancer and neurodegenerative diseases. However, no small-molecule inhibiting protein SUMOylation has been reported so far. Here, we report inhibition of SUMOylation by ginkgolic acid and its analog, anacardic acid. Ginkgolic acid and anacardic acid inhibit protein SUMOylation both in vitro and in vivo without affecting in vivo ubiquitination. Binding assays with a fluorescently labeled probe showed that ginkgolic acid directly binds E1 and inhibits the formation of the E1-SUMO intermediate. These studies will provide not only a useful tool for investigating the roles of SUMO conjugations in a variety of pathways in cells, but also a basis for the development of drugs targeted against diseases involving aberrant SUMOylation.

AB - Protein modification by small ubiquitin-related modifier proteins (SUMOs) controls diverse cellular functions. Dysregulation of SUMOylation or deSUMOylation processes has been implicated in the development of cancer and neurodegenerative diseases. However, no small-molecule inhibiting protein SUMOylation has been reported so far. Here, we report inhibition of SUMOylation by ginkgolic acid and its analog, anacardic acid. Ginkgolic acid and anacardic acid inhibit protein SUMOylation both in vitro and in vivo without affecting in vivo ubiquitination. Binding assays with a fluorescently labeled probe showed that ginkgolic acid directly binds E1 and inhibits the formation of the E1-SUMO intermediate. These studies will provide not only a useful tool for investigating the roles of SUMO conjugations in a variety of pathways in cells, but also a basis for the development of drugs targeted against diseases involving aberrant SUMOylation.

UR - http://www.scopus.com/inward/record.url?scp=60649088334&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=60649088334&partnerID=8YFLogxK

U2 - 10.1016/j.chembiol.2009.01.009

DO - 10.1016/j.chembiol.2009.01.009

M3 - Article

C2 - 19246003

AN - SCOPUS:60649088334

VL - 16

SP - 133

EP - 140

JO - Cell Chemical Biology

JF - Cell Chemical Biology

SN - 2451-9448

IS - 2

ER -